全文获取类型
收费全文 | 4828篇 |
免费 | 335篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 65篇 |
儿科学 | 170篇 |
妇产科学 | 207篇 |
基础医学 | 708篇 |
口腔科学 | 107篇 |
临床医学 | 468篇 |
内科学 | 975篇 |
皮肤病学 | 136篇 |
神经病学 | 412篇 |
特种医学 | 401篇 |
外科学 | 592篇 |
综合类 | 39篇 |
预防医学 | 216篇 |
眼科学 | 86篇 |
药学 | 335篇 |
肿瘤学 | 279篇 |
出版年
2022年 | 27篇 |
2021年 | 46篇 |
2020年 | 35篇 |
2019年 | 55篇 |
2018年 | 65篇 |
2017年 | 58篇 |
2016年 | 71篇 |
2015年 | 75篇 |
2014年 | 100篇 |
2013年 | 110篇 |
2012年 | 145篇 |
2011年 | 185篇 |
2010年 | 153篇 |
2009年 | 139篇 |
2008年 | 182篇 |
2007年 | 220篇 |
2006年 | 211篇 |
2005年 | 174篇 |
2004年 | 183篇 |
2003年 | 160篇 |
2002年 | 161篇 |
2001年 | 153篇 |
2000年 | 189篇 |
1999年 | 140篇 |
1998年 | 105篇 |
1997年 | 129篇 |
1996年 | 125篇 |
1995年 | 89篇 |
1994年 | 63篇 |
1993年 | 80篇 |
1992年 | 120篇 |
1991年 | 105篇 |
1990年 | 104篇 |
1989年 | 114篇 |
1988年 | 98篇 |
1987年 | 77篇 |
1986年 | 81篇 |
1985年 | 93篇 |
1984年 | 46篇 |
1983年 | 67篇 |
1982年 | 34篇 |
1981年 | 40篇 |
1980年 | 35篇 |
1979年 | 45篇 |
1978年 | 32篇 |
1977年 | 40篇 |
1976年 | 31篇 |
1975年 | 29篇 |
1973年 | 30篇 |
1972年 | 30篇 |
排序方式: 共有5196条查询结果,搜索用时 328 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
4.
5.
6.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
7.
J M Esteban J A Kuhn B Felder J Y Wong H Battifora J D Beatty P M Wanek J E Shively 《Cancer research》1991,51(14):3802-3806
We have previously shown that the colon carcinoma (LS174T) xenografts that emerged shortly after radioimmunotherapy with 90Y-labeled anti-CEA monoclonal antibody (MAb) ZCE025 lacked significant expression of CEA in comparison with the untreated tumors. The present study was designed to establish if the immunophenotype of the treated tumors was the result of CEA specific therapy and if the effect was permanent. Athymic mice bearing LS174T tumors were treated either with 120 mu Ci of 90Y-ZCE025, an equal dose of 90Y-96.5 (nonspecific MAb), or received no treatment. When the treated tumors grew to approximately 1.5 cm in diameter (6 weeks after therapy), they were resected and aliquoted to be transplanted to other mice, plated in tissue culture, fixed in formalin, and homogenized for CEA quantitation. The procedure was repeated 3 times (a total of 4 months after treatment). The CEA content was evaluated 2 and 6 weeks after therapy and when the tumors were transplanted. We confirmed a 4-fold decrease of CEA in the resurgent tumors 6 weeks after specific 90Y-ZCE025 therapy, which was twice the decrease experienced by the tumors treated with nonspecific 90Y-96.5, indicating substantial and specific killing of CEA-expressing cells. The CEA content slowly but progressively increased with each new pass of the tumor in the mice, reaching approximately one-half the value of the controls at the end of the study. The resurgent tumors were also studied by immunohistochemistry with MAbs detecting different epitopes of CEA, keratin, TAG-72, and epithelial membrane antigen to evaluate possible additional immunophenotypic changes induced by radioimmunotherapy. Only the expression of TAG-72 (recognized by MAb B72.3) increased immediately after therapy, but it returned to the original levels by the end of the study. These results suggest that: (a) specific radioimmunotherapy with 90Y-ZCE025 selectively kills cells that express higher levels of CEA; (b) the immunophenotype of the surviving fraction of the tumor appears to slowly revert to its original form; and (c) other tumor markers unrelated to CEA can also be affected. These observations have important implications for the design of radioimmunotherapy trials. 相似文献
8.
9.
D S Rao R Antonelli K R Kane J E Kuhn C Hetnal 《Henry Ford Hospital medical journal》1991,39(1):41-44
Coexistent primary hyperparathyroidism and monoclonal gammopathy, although rare, has been reported previously by a number of investigators. We report four patients with such an occurrence who were seen between 1976 and 1988. Another patient with primary hyperparathyroidism also had multiple myeloma and was in remission for 12 years. These patients represent approximately 1% of the 386 patients with primary hyperparathyroidism seen during the same 12-year period. Although several mechanisms have been proposed to explain this concurrence, we believe it is the result of a chance occurrence. A review of the literature, an estimate of the chance occurrence of coincidental monoclonal gammopathy, benign or malignant, in patients with primary hyperparathyroidism, and some practical implications of this interesting coexistence are presented. 相似文献
10.
Dr. med. H. Kuhn Dr. med. R. Gerdes-Kuhn Prof. Dr. med. H.-H. Küster 《Fu? & Sprunggelenk》2007,5(1):26-31
The Cinderella shoe syndrome specifies a commonly observed, not yet labeled disproportion of footwear and the morphologic conditions of the wearer. Disproportioned shoes and socks are worn–frequently unconsciously–due to personal reasons, fashion trends, misinformation and wrong advice; they can induce severe foot disorders. The Cinderella shoe syndrome has an important significance within the development, the treatment and the recurrence-prophylaxis of foot disorders, as well as in the assessment of possible reasons for recurrence after foot surgery. To recognize it, to treat individual psychologic reasons, to give support in the choice of footwear, to inform about and to change social reasons are all challenges of the foot surgeon. 相似文献